annual report

58 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

TOP Ships Files 2025 Annual Report, Providing Full-Year Tanker Market Insights

TOP Ships Inc. filed its 2025 Form 20-F annual report, offering investors comprehensive tanker sector performance data and financial disclosures.
TOPSForm 20-Fannual report
BenzingaBenzinga··Prnewswire

Rebranded DOOR Reports 24% Revenue Growth But Posts $53.7M Loss

DOOR (formerly Latch) revenue reached $70.1M in 2025, up 24% YoY, but net losses widened to $53.7M due to impairments and inventory charges.
LTCHnet lossrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sanoma Reports €1.3B Revenue, 14.4% Operating Margin in 2025 Annual Results

Sanoma reports €1.3B revenue with 14.4% adjusted operating margin in 2025, completing share buyback while advancing ESG compliance.
SWYBYfinancial resultsannual report
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tenaris Halts Share Buyback Program as Company Files 2025 Annual Report

Tenaris files 2025 annual report with SEC and Luxembourg exchange; terminates second tranche of USD 1.2B share buyback program, signaling cautious capital allocation amid energy sector uncertainty.
TSannual reportSEC filing
GlobeNewswire Inc.GlobeNewswire Inc.··Alvotech

Alvotech Files 2025 Annual Report, Providing Full Financial Disclosure to US Investors

Alvotech files 2025 Annual Report on Form 20-F with SEC, providing comprehensive financial disclosures to U.S. investors via SEC Edgar and company website.
ALVOALVOWbiotechForm 20-F
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Alvotech Expands Pipeline With 9 Biosimilar Candidates in Development

Alvotech files 2025 annual report with SEC, reporting five marketed biosimilars and nine additional candidates in development across therapeutic areas.
ALVOALVOWregulatory complianceForm 20-F
GlobeNewswire Inc.GlobeNewswire Inc.··Alvotech

Alvotech Expands Biosimilar Pipeline With Five Approved Drugs, Nine in Development

Alvotech files 2025 annual report showing five approved biosimilars and nine pipeline candidates across multiple therapeutic areas, positioning the company amid rapid biosimilar market growth.
ALVOALVOWregulatory complianceForm 20-F
GlobeNewswire Inc.GlobeNewswire Inc.··Alvotech

Icelandic Biotech Alvotech Files 2025 Annual Report, Expands Global Biosimilar Footprint

Alvotech files 2025 Form 20-F, revealing operations across six continents as the Icelandic biosimilar developer pursues international market expansion.
ALVOALVOWbiotechForm 20-F
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Costamare Reports 2025 Results: 31-Vessel Fleet Powers Dry Bulk Shipping Operations

Costamare Bulkers files 2025 annual report, operating 31 dry bulk vessels with 2.8M DWT capacity amid volatile shipping markets.
CMDBForm 20-Fannual report
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Frontline Reshuffles Board as Two Directors Step Down

Frontline plc announces resignations of two board directors Richard C. Prince and Ørjan Svanevik. Company files 2025 annual report.
FROcorporate governanceannual report
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Magna International Releases 2025 Results; Virtual Shareholder Meeting Set for May

Magna International releases 2025 Annual Report; announces virtual-only shareholder meeting on May 4, 2026. Global automotive supplier maintains operations in 28 countries.
MGAannual reportfinancial statements
GlobeNewswire Inc.GlobeNewswire Inc.··Frontline Plc

Frontline Reports 2025 Results Amid Leadership Transition

Frontline plc files 2025 annual report; board members Richard C. Prince and Ørjan Svanevik resign. Orderly leadership transition in major tanker shipping operator.
FROcorporate governanceannual report
BenzingaBenzinga··Prnewswire

Aker BP Releases 2025 Annual Report With Integrated Sustainability Disclosures

Aker BP releases comprehensive 2025 Annual Report integrating financial, sustainability, and compensation disclosures with updated reserve statements.
AKRBYfinancial reportingsustainability
GlobeNewswire Inc.GlobeNewswire Inc.··Fortuna Mining Corp.

Fortuna Mining Files Annual Report; Diamba Sud Gold Project Expands Resource Base

Fortuna Mining filed 2025 Form 40-F with SEC. Diamba Sud gold project resources expanded 73%, featuring 6.0 g/t gold intersections across three operational mines.
FSMannual reportgold
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Alamos Gold Completes Annual Filings, Signals Growth Projects Ahead

Alamos Gold files 2025 annual report with SEC and Canadian authorities. Canadian intermediate gold producer operates three North American mines with expansion projects underway.
AGIannual reportfinancial statements
BenzingaBenzinga··Prnewswire

Getinge Reports SEK 35B Revenue, Navigates Tariffs and Currency Headwinds

Getinge reported SEK 35B revenue with organic growth across all segments, maintaining margins despite SEK 1B in tariff and currency headwinds. Dividend proposed at SEK 4.75 per share.
GNGBYregulatory compliancedividend
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Borregaard Maintains Stable A- Rating as Specialty Chemicals Firm Solidifies Credit Profile

Scope Ratings affirms Borregaard ASA's A-/Stable rating for both issuer and debt. Norwegian specialty chemicals firm launches 2026 employee share program.
BRGAYannual reportcredit rating
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Brookfield Wealth Solutions Boosts Distribution After Filing 2025 Annual Results

Brookfield Wealth Solutions completes 2025 annual filings with SEC and Canadian regulators, announces year-end results and increases quarterly distribution.
BNBNHBNJBNTannual reportfinancial statements
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Marex Group Files 2025 Annual Report, Providing Full-Year Financial Disclosure

Marex Group ($MRX) files 2025 Form 20-F annual report with SEC, disclosing comprehensive financial performance and operational metrics to shareholders.
MRXForm 20-Fannual report
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Polyrizon Files 2025 Annual Report as Biotech Pursues Intranasal Hydrogel Technology

Polyrizon files 2025 annual report detailing its pre-clinical intranasal hydrogel technology platform targeting viral and allergen protection.
PLRZForm 20-Fannual report